Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

patients

‘Trust me, I’m from the pharmaceutical industry?’

As UK firms prepare to publish their HCP payments, are numbers alone enough to improve trust in the industry?

- PMLiVE

Massive uncertainty is the new norm

How to make it work for your company

- PMLiVE

Europe delays EMA relocation decision

Will resolve the issue in November, one month later than expected

Using insights to effect behaviour change

The days when medical communication simply aimed to raise awareness of clinical challenges are well and truly over. In recent years, we have seen a clear shift towards changing physicians’...

Lucid Group Communications Limited

- PMLiVE

Asian patient groups give pharma above average marks for reputation

PatientView survey finds 49% believe sector has a good corporate reputation

- PMLiVE

Lucid strikes £11m investment deal with equity firm LDC

Will use the new funds to underpin its infrastructure as it grows

- PMLiVE

Spotlight on Events

Porterhouse has delivered many successful global programmes in 2017 so far. Read about our dedicated events team ...

Porterhouse Medical Group

17 In Search of the Invisible Army

The caregivers' story

Havas Lynx

- PMLiVE

All five of Lucid’s entries reach the shortlist for Communiqué 2017

Lucid Group is thrilled to learn that all its entries for the 2017 Communiqué Awards have been shortlisted as finalists! The categories include: Communications Consultancy of the Year Lucid Group   Excellence in Communications via...

Lucid Group Communications Limited

- PMLiVE

Power to the people

The rise of patient engagement

Generation Now: the impact of the millennial HCP on our world

Millennials are criticised as narcissistic, entitled and technology-obsessed, but our new campaign shows millennial healthcare professionals – mHCPs – in a different light. They have certainly grown up in a...

Havas Lynx

german flag

Germany’s pharma market set for stable growth

Annual growth of 4.9% expected over next four years

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links